谷歌Chrome浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A PHASE I TRIAL OF TARGETED IMMUNOTHERAPY WITH DARATUMUMAB FOLLOWING MYELOABLATIVE TOTAL BODY IRRADIATION (TBI)-BASED CONDITIONING AND ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATON IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH HIGH-RISK T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA (T- ALL/T-LLy) (ALLO-T-DART) (IND 159396): A PTCTC FACILITATED STUDY

T. Quigg,A. Flower,D. Teachey,M. Lim,Y. Chu,L. Harrison,E. Morris,A. Gardenswartz,J. Hochberg,M. Ozkaynak,J. Rosenblum,J. Milner, K. Pehlivan,O. Levendoglu-Tugal, S. Fabricatore,K. Wolownik,J. Ayello, O. Rigot,L. Klejmont, M. Campbell, I. Gonzalez, N. Otero, A. Budhram, E. Mintzer, H. Mahanti, J. Dufresne, D. Liu, T. Ahmed, A. Steinberg, R. Sweeney, P. McHale,H. Islam,P. Gerard, C. Moorthy,S. Voss,R. Miles, A. Audino, X. Mo, J. Stanek, A. Olshen,M. Hermiston,A. Seif,M. Cairo

Leukemia Research（2022）

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要